Results 181 to 190 of about 4,095,028 (342)

Echo contrast medium: How the use of contrast echocardiography (ultrasound contrast agents) can improve patient care. [PDF]

World J Methodol
English K.
europepmc   +1 more source

H-8. Myelography and Extradurography of the Spinal Canal with Water Soluble Contrast Medium

, 1971
Toru Yoshida, Susumu Kato, Hiroshi Sugiura, Kentaro Mimatsu   +3 more
openalex   +2 more sources

Investigating the cell of origin and novel molecular targets in Merkel cell carcinoma: a historic misnomer

Molecular Oncology, EarlyView.
This study indicates that Merkel cell carcinoma (MCC) does not originate from Merkel cells, and identifies gene, protein & cellular expression of immune‐linked and neuroendocrine markers in primary and metastatic Merkel cell carcinoma (MCC) tumor samples, linked to Merkel cell polyomavirus (MCPyV) status, with enrichment of B‐cell and other immune cell
Richie Jeremian, Sriraam Sivachandran, Melissa Galati, Brandon Ramchatesingh, Hibo Rijal, Johnny Hanna, Elena Netchiporouk, May Chergui, Margaret Redpath, Samy Abou Setah, Ivan V. Litvinov   +10 more
wiley   +1 more source

Excessive Contrast Medium Leakage in Hyperperfusion Syndrome [PDF]

, 2018
Brekenfeld, C., Do, D. D., Fung, C., Gralla, J., Mordasini, P., Schroth, G.   +5 more
core  

The influence of ROS1 fusion partners and resistance mechanisms in ROS1‐TKI‐treated non‐small cell lung cancer patients

Molecular Oncology, EarlyView.
This real‐world study of ROS1+ NSCLC highlights fusion diversity, treatment outcomes with crizotinib and lorlatinib, and in vitro experiments with resistance mechanisms. G2032R drives strong resistance to ROS1‐targeted TKIs, especially lorlatinib. Fusion partner location does not affect overall survival to crizotinib or lorlatinib. Findings support the
Fenneke Zwierenga, Christa Dijkhuizen, Patrick Korthuis, Wim Timens, Harry Groen, Jeroen Hiltermann, Anke van den Berg, Lyndsay Drayer, Anthonie van der Wekken   +8 more
wiley   +1 more source

Prolonged retention of oil-based iodinated contrast medium observed on plain abdominal radiograph after cesarean section: A case report. [PDF]

World J Clin Cases
Morita A, Kakinuma T, Segawa A, Harada S, Takae S, Tamura M, Suzuki N.   +6 more
europepmc   +1 more source

Myelography with Iotrolan, an Isotonic Water Soluble Contrast Medium

, 1989
Goichi Yoshida, Atsushi Taguchi, Kyoe Itô, Yutaka Nakajima, M. Yamada, Mashatoshi Miyazaki   +5 more
openalex   +2 more sources

A bioinformatics screen identifies TCF19 as an aggressiveness‐sustaining gene in prostate cancer

Molecular Oncology, EarlyView.
Gene expression meta‐analysis in multiple prostate cancer patient cohorts identifies Transcription factor 19 (TCF19) as an aggressiveness‐sustaining gene with prognostic potential. TCF19 is a gene repressed by androgen signaling that sustains core cancer‐related processes such as vascular permeability or tumor growth and metastasis.
Amaia Ercilla, Jana R. Crespo, Saioa Garcia‐Longarte, Marta Fidalgo, Sara del Palacio, Natalia Martin‐Martin, Onintza Carlevaris, Ianire Astobiza, Sonia Fernández‐Ruiz, Marc Guiu, Laura Bárcena, Isabel Mendizabal, Ana M. Aransay, Mariona Graupera, Roger R. Gomis, Arkaitz Carracedo   +15 more
wiley   +1 more source

Intestinal Vicarious Contrast Medium Excretion on Delayed Computed Tomography in Dogs with Protein-Losing Enteropathy. [PDF]

Vet Radiol Ultrasound
Lee Y, Choi H, Lee YW, Lee K, Choi S.
europepmc   +1 more source

Refining the radiation and contrast medium dose in weight-grouped scanning protocols for coronary CT angiography. [PDF]

J Appl Clin Med Phys, 2023
Zhang Y, Wang Y, Li J, Zhang G, Di A, Yuan H.   +5 more
europepmc   +1 more source